NASDAQ
Shield Therapeutics plc (SHIEF) has a free cash flow growth of -316.70% as of Friday, May 29, 2026. This represents a 278.30% decrease compared to its 12-month average of 177.63%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.